Yüklüyor......
Current and future systemic treatment options in metastatic pancreatic cancer
Although pancreatic adenocarcinoma is the fourth leading cause of cancer death, only modest improvement has been observed in the past two decades, single agent gemcitabine has been the only standard treatment in patients with advanced disease. Recently newer agents such as nab-paclitaxel, nimotuzuma...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Pioneer Bioscience Publishing Company
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110498/ https://ncbi.nlm.nih.gov/pubmed/25083302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.030 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|